First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - ACCESS BIOTECH CONSULTING LTD

ANALYSIS
Credit Risk Update: ACCESS BIOTECH CONSULTING LTD, BRACKEN HOUSE 3 FERNHILL WAY, WOLVEY, RUGBY, WARWICKSHIRE, LE10 3LP. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 30 November 2023. The company was incorporated on 3 November 2011.

The accounts next due date is 31 August 2025. There are no mortgages.

The above was based on public record information as at 23 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 07834202
Date Incorporated: 3 November 2011
Date Latest Accounts: 30 November 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: DSP MANAGEMENT CONSULTING LTD
Registered Number: 07834202
Annual Return: 3 November 2015
Registered Office: BRACKEN HOUSE 3 FERNHILL WAY, WOLVEY, RUGBY, WARWICKSHIRE, LE10 3LP
SIC Code and Operations: 99999
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

ACCESS BIOTECH CONSULTING LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 3 May 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
SC417723 ACCESS BLASTING AND COATINGS LTD Active - Proposal to Strike off
11881886 ACCESS BLINDS LTD Active
11862907 ACCESS BLOCK MANAGEMENT LTD Active
07938450 ACCESS BODYSHOP LTD Dissolved
NI632437 ACCESS BOOKINGS (N.I.) LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd